Skei Oncotherapeutics Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 27-06-2024
- Paid Up Capital ₹ 0.10 M
as on 27-06-2024
- Company Age 3 Year, 9 Months
About Skei Oncotherapeutics
The Company is engaged in the Research & Development Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ram Asrey, Kesavan Venkitasamy, Subburaj Magalakshmi, and Three other members serve as directors at the Company.
- CIN/LLPIN
U73200TN2021PTC142058
- Company No.
142058
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Mar 2021
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Madurai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Skei Oncotherapeutics?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Asrey  | Additional Director | 07-Dec-2021 | Current |
| Kesavan Venkitasamy | Additional Director | 07-Dec-2021 | Current |
| Subburaj Magalakshmi | Director | 15-Mar-2021 | Current |
| Muthuraj Prakash | Director | 15-Mar-2021 | Current |
| Priyanka Ponnusamy | Additional Director | 10-Dec-2021 | Current |
| Samy Jayakumar | Additional Director | 10-Dec-2021 | Current |
Financial Performance and Corporate Structure Insights of Skei Oncotherapeutics.
Enhance accessibility to Skei Oncotherapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Skei Oncotherapeutics?
Unlock access to Skei Oncotherapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Kamrusepa Pharmaceutical Private LimitedActive 5 years 3 months
Kesavan Venkitasamy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Skei Oncotherapeutics?
Skei Oncotherapeutics has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skei Oncotherapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skei Oncotherapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
